Test Compendium
Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 1 - 25 of 352
FISH ALK
FISHFISH ALK Methodology FISH Test Description Probes ALK(Non-Heme) Disease Non-small cell lung cancer, and neuroblastomaALK Rearrangement by FISH is designed to detect loss rearrangement (breakapart) of the
Ki67
Immunohistochemistry (IHC)Ki67 Methodology Immunohistochemistry (IHC) Test Description Disease Breast Cancer Lymphomas (NHL)Marker of cell proliferation. Labile, nonhistone nuclear protein expressed in G1, S, G2 and M phases
PgR
Immunohistochemistry (IHC)PgR Alternative Name Progesterone Receptor Methodology Immunohistochemistry (IHC) Test Description Disease Breast cancerEstrogen and progesterone act through intra-nuclear receptors, ER and PR, which belong
TP53
Immunohistochemistry (IHC)TP53 Methodology Immunohistochemistry (IHC) Test Description Disease Li-Fraumeni Syndrome, breast cancer, osteosarcoma, soft tissue sarcoma, some leukemias and lymphomas, papilloma of choroid plexus, brain
ER
Immunohistochemistry (IHC)ER Alternative Name Estrogen Receptor Methodology Immunohistochemistry (IHC) Test Description Disease Breast CancerEstrogen and progesterone act through intra-nuclear receptors, ER and PR, which belong
EBER (ISH)
In Situ Hybridization (ISH)EBER (ISH) Alternative Name Epstein-Barr Virus by ISH Methodology In Situ Hybridization (ISH) Test Description Disease EBERs are abundantly expressed during persistent infection, including EBV-associated
Kappa
In Situ Hybridization (ISH)Kappa Alternative Name Kappa by ISH Methodology In Situ Hybridization (ISH) Test Description Disease Plasma cell dyscrasias (MM,MGUS,WM), some lymphoid neoplasms, amyloidosisHuman lg-kappa CISH Probe is
Lambda
In Situ Hybridization (ISH)Lambda Alternative Name Lambda by ISH Methodology In Situ Hybridization (ISH) Test Description Disease Plasma cell dyscrasias (MM,MGUS,WM), some lymphoid neoplasms, amyloidosisLambda mRNA CISH Probe is
ALK (Lymphoma)
FISHALK (Lymphoma) Alternative Name Anaplastic lymphoma kinase, (2p23) Methodology FISH Test Description Probes ALK (2p23) Disease This gene has been found to be rearranged, mutated, or amplified in a series
FGFR1/D8Z2
FISHFGFR1/D8Z2 Alternative Name FISH Eosinophilia probe Methodology FISH Test Description Probes FGFR1/D8Z2 (8p12/8p11.1-q11.1) Disease Myeloproliferative neoplasm, Osteoglophonic Dysplasia, squamous cell
FIP1L1/CHIC2/PDGFRA
FISHFIP1L1/CHIC2/PDGFRA Alternative Name FISH Eosinophilia probe Methodology FISH Test Description Probes FIP1L1/CHIC2/PDGFRA (4q12) Disease Myeloid and/or lymphoid neoplasms associated with eosinophilia and
PDGFRB
FISHPDGFRB Alternative Name FISH Eosinophilia probe Methodology FISH Test Description Probes PDGFRB (5q32-q33) Disease Myeloid and/or lymphoid neoplasms associated with eosinophilia and PDGFRB abberations,
PCM1/JAK2
FISHPCM1/JAK2 Alternative Name FISH Eosinophilia probe Methodology FISH Test Description Probes PCM1/JAK2 (8p22/9p24.1) Disease Myeloid and lymphoid neoplasms with eosinophilia and PCM1/JAK2 translocation.PCM:
FISH Eosinophilia Panel
FISHFISH Eosinophilia Panel Methodology FISH Test Description Probes FGFR1/D8Z2 (8p12/8p11.1-q11.1) & FIP1L1/CHIC2/PDGFRA (4q12) & PCM1/JAK2 (8p22/9p24.1) & PDGFRB (5q32-q33)FGFR1/D8Z2 (8p12/8p11.1-q11.1)
FISH RET
FISHFISH RET Methodology FISH Test Description Probes RET (10q11.21) Disease Non-small cell lung cancer, Papillary thyroid carcinomaIt is designed to detect chromosomal rearrangements involving the RET proto-oncogene
PTEN Deletion (1p36.31/1q25.3)
FISHPTEN Deletion (1p36.31/1q25.3) Methodology FISH Test Description Probes 1p36.31/1q25.3 Disease Glial tumors, neuroblastoma, multipl myeloma, MPNDeletions of the 1p36 and 19q13 region genes are seen in
PTEN Deletion (19p13/19q13)
FISHPTEN Deletion (19p13/19q13) Methodology FISH Test Description Probes 19p13/19q13 Disease Glial tumors, microdeletion/microduplication syndrome at 19p13.3Deletions of the 1p36 and 19q13 region genes are
PTEN Deletions (10q23.2-q23.31/10p11.1-q11.1)
FISHPTEN Deletions (10q23.2-q23.31/10p11.1-q11.1) Methodology FISH Test Description Probes 10q23.2-q23.31/10p11.1-q11.1 Disease Brain tumors, HNSCC, prostate cancer, melanoma, cervix cancer, endometrium cancer,
Brain Cancer FISH Panel
FISHBrain Cancer FISH Panel Methodology FISH Test Description Probes (1p36.31/1q25.3 & 19p13.3/19q13.32-q13.33 & 10q23.2-q23.31/10p11.1-q11.1) Disease Brain cancerDeletions of the 1p36 and 19q13 region
KMT2A
FISHKMT2A Alternative Name Mixed-lineage leukemia (MLL) Methodology FISH Test Description Probes 11q23.3 Disease Wiedemann-Steiner Syndrome and AML with t(9;11), ALLThis gene encodes a transcriptional coactivator
ETV6/RUNX1
FISHETV6/RUNX1 Methodology FISH Test Description Probes 12p13.2/21q22.12 Disease Myeloid Malignancy (e.g., AML) and Lymphoid Malignancy (e.g., ALL).ETV6/RUNX1 is the most common fusion gene in childhood ALL.
IGH
FISHIGH Alternative Name Immunoglobulin heavy chain Methodology FISH Test Description Probes 14q32.33 Disease Plasma Cell Leukemia; B-cell Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia (CLL); Multiple
ABL1/BCR
FISHABL1/BCR Alternative Name ABL1/BCR fusion gene, Philadelphia chromosome Methodology FISH Test Description Probes 9q34.11-q34.13/22q11.22-q11.23 Disease CML, some ALL and AML (rarely).ABL1/BCR fusion gene
ALL FISH Panel
FISHALL FISH Panel Methodology FISH Test Description Probes ( 11q23.3 & 12p13.2/21q22.12 & 14q32.33 & 9q34.11-q34.13/22q11.22-q11.23) Disease Wiedemann-Steiner Syndrome, Plasma Cell Leukemia; B-cell
PML/RARA
FISHPML/RARA Methodology FISH Test Description Probes 15q24.1/17q12-q21.2 Disease acute promyelocytic leukemia (APL).The PML-RARA fusion is the result of a recurrent, balanced translocation between chromosomes
